# Thymosin Alpha-1 combo for hepatitis C non-responders

Source: https://pepvault.app/research/thymosin-alpha-1-poo-2004

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [Thymosin Alpha-1](https://pepvault.app/research#thymosin-alpha-1)

Clinical trial · people

# Thymosin Alpha-1 combo: 47.8% viral response at 24 weeks in hep C

Checked against the paper November 2026 Clinical trial [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

An early, uncontrolled pilot hints that thymalfasin in a triple combination may help some hepatitis C patients who failed prior therapy, but its own share of the effect remains untested.

- **Kind:** Clinical trial
- **Studied in:** People
- **Number studied:** 23
- **Published:** 2004
- **Journal:** J Gastroenterol Hepatol

## What they tested

The team tested whether a three-drug combination of thymalfasin, peginterferon alfa-2a and ribavirin could control the virus in people with chronic hepatitis C whose earlier interferon and ribavirin treatment had failed.

## How the study was done

A small multicenter pilot trial in which 23 patients with chronic hepatitis C who had not cleared the virus on prior interferon and ribavirin all received the triple combination, with interim results at 24 weeks. There was no comparison group.

<!--promo-->

PepVault for iPhone

## Taking Thymosin Alpha-1? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

A viral response was seen in 60.8% of patients at week 12 and in 47.8% at week 24. The researchers saw these early results as reason to keep studying the combination.

## What it doesn’t show

With only 23 patients and no control arm, the trial can't show how much thymalfasin added beyond peginterferon and ribavirin. These are interim 24-week results from a pilot study, so they don't show whether the response lasted after treatment.

## The paper

Poo et al. Triple combination of thymalfasin, peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior interferon and ribavirin treatment: 24-week interim results of a pilot study. J Gastroenterol Hepatol. 2004.

- [PubMed (PMID 15546256)](https://pubmed.ncbi.nlm.nih.gov/15546256/)
- [The paper (DOI 10.1111/j.1440-1746.2004.03634.x)](https://doi.org/10.1111/j.1440-1746.2004.03634.x)

## The compound

- [Thymosin Alpha-1: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/thymosin-alpha-1)
- [Thymosin Alpha-1 dose guide](https://pepvault.app/lab/dosage/thymosin-alpha-1)

## With this study

### Thymosin Alpha-1

- [Thymosin Alpha-1: the full reference](https://pepvault.app/peptides/thymosin-alpha-1)
- [Thymosin Alpha-1 dose guide](https://pepvault.app/lab/dosage/thymosin-alpha-1)

### Mixing charts

- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/thymosin-alpha-1-10mg)

### Studies

- [Thymosin alpha-1: lower COVID-19 death risk (RR 0.59) in meta-analysis](https://pepvault.app/research/thymosin-alpha-1-soeroto-2023)
- [Thymosin Alpha-1 vs interferon in hepatitis B: better at follow-up](https://pepvault.app/research/thymosin-alpha-1-yang-2008)
- [Thymosin alpha-1 lowered infections after colorectal cancer surgery](https://pepvault.app/research/thymosin-alpha-1-niu-2024)
- [All 6 studies](https://pepvault.app/research#thymosin-alpha-1)

### Compared with

- [Thymosin Alpha-1 vs Thymosin Beta-4](https://pepvault.app/peptides/compare/thymosin-alpha-1-vs-thymosin-beta-4)
- [Thymosin Alpha-1 vs LL-37](https://pepvault.app/peptides/compare/thymosin-alpha-1-vs-ll-37)
- [Thymosin Alpha-1 vs Thymalin](https://pepvault.app/peptides/compare/thymosin-alpha-1-vs-thymalin)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

## More studies on Thymosin Alpha-1

- [Thymosin alpha-1: lower COVID-19 death risk (RR 0.59) in meta-analysis](https://pepvault.app/research/thymosin-alpha-1-soeroto-2023) Meta-analysis · people · 2023
- [Thymosin Alpha-1 vs interferon in hepatitis B: better at follow-up](https://pepvault.app/research/thymosin-alpha-1-yang-2008) Meta-analysis · people · 2008
- [Thymosin alpha-1 lowered infections after colorectal cancer surgery](https://pepvault.app/research/thymosin-alpha-1-niu-2024) Randomized trial · people · 2024
- [Thymosin alpha-1: 3 deaths vs 7 in dialysis COVID-19 pilot so far](https://pepvault.app/research/thymosin-alpha-1-tuthill-2023) Randomized trial · people · 2023
- [Thymosin Alpha-1 combo: 30.0% pCR before gastric cancer surgery](https://pepvault.app/research/thymosin-alpha-1-xu-2026) Clinical trial · people · 2026
- [Every study on Thymosin Alpha-1](https://pepvault.app/research#thymosin-alpha-1)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking Thymosin Alpha-1? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking Thymosin Alpha-1? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### Thymosin Alpha-1

- [Thymosin Alpha-1: the full reference](https://pepvault.app/peptides/thymosin-alpha-1)
- [Thymosin Alpha-1 dose guide](https://pepvault.app/lab/dosage/thymosin-alpha-1)

### Mixing charts

- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/thymosin-alpha-1-10mg)

### Studies

- [Thymosin alpha-1: lower COVID-19 death risk (RR 0.59) in meta-analysis](https://pepvault.app/research/thymosin-alpha-1-soeroto-2023)
- [Thymosin Alpha-1 vs interferon in hepatitis B: better at follow-up](https://pepvault.app/research/thymosin-alpha-1-yang-2008)
- [Thymosin alpha-1 lowered infections after colorectal cancer surgery](https://pepvault.app/research/thymosin-alpha-1-niu-2024)
- [All 6 studies](https://pepvault.app/research#thymosin-alpha-1)

### Compared with

- [Thymosin Alpha-1 vs Thymosin Beta-4](https://pepvault.app/peptides/compare/thymosin-alpha-1-vs-thymosin-beta-4)
- [Thymosin Alpha-1 vs LL-37](https://pepvault.app/peptides/compare/thymosin-alpha-1-vs-ll-37)
- [Thymosin Alpha-1 vs Thymalin](https://pepvault.app/peptides/compare/thymosin-alpha-1-vs-thymalin)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

<!--promo-->

PepVault for iPhone

## Taking Thymosin Alpha-1? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on Thymosin Alpha-1](https://pepvault.app/research#thymosin-alpha-1)

## The library

- [Thymosin Alpha-1](https://pepvault.app/peptides/thymosin-alpha-1)
- [Thymosin Alpha-1 dose guide](https://pepvault.app/lab/dosage/thymosin-alpha-1)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
